1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
PXL01 alters macrophage response with no effect on axonal outgrowth or Schwann cell response after nerve repair in rats
(
- Contribution to journal › Article
- 2023
-
Mark
How proven is a 'proven intervention'? Ethics of placebo controls in light of conditional approval programs
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Understanding voluntariness of consent in first-in-human cell therapy trials
(
- Contribution to journal › Article
- 2019
-
Mark
Stem cell culture conditions and stability : a joint workshop of the PluriMes Consortium and Pluripotent Stem Cell Platform
(
- Contribution to journal › Article
- 2017
-
Mark
The ethics of withdrawal : The case of follow-up from first-in-human clinical trials
(
- Contribution to journal › Article
-
Mark
Identification of regenerative roadblocks via repeat deployment of limb regeneration in axolotls
(
- Contribution to journal › Article
- 2016
-
Mark
Making it personal : the prospects for autologous pluripotent stem cell-derived therapies
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Comparability : Manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2015
(
- Contribution to journal › Article
- 2014
-
Mark
Stem cell therapies for Parkinson's disease : are trials just around the corner?
(
- Contribution to journal › Debate/Note/Editorial